The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment.
Schicho R, Bashashati M, Bawa M, McHugh D, Saur D, Hu HM, Zimmer A, Lutz B, Mackie K, Bradshaw HB, McCafferty DM, Sharkey KA, Storr M.
Schicho R, et al.
Inflamm Bowel Dis. 2011 Aug;17(8):1651-64. doi: 10.1002/ibd.21538. Epub 2010 Nov 15.
Inflamm Bowel Dis. 2011.
PMID: 21744421
Free PMC article.